<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7564663/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <p>Evolving strategies for ASFV genetically engineered vaccines.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">Sequence Source</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Gene/Protein</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Vector/System</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Adjuvant</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Specific Antibodies</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-5-.">Neutralizing Antibody</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-6-.">Cellular Immunity</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-7-.">Protection</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-8-.">Reference</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td colspan="9" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Protein-based subunit vaccines</td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">E75CV</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HA (CD2v)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Baculovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Freund’s</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Homologous protection (3/3) 
    <br/>Dose dependent 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B87-vaccines-08-00531" ref-type="bibr">87</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">E75</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p54,p30</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Baculovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Freund’s</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Partial protection (3/6),</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B88-vaccines-08-00531" ref-type="bibr">88</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">E75</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p54/p30 chimera</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Baculovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Freund’s</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Homologous protection (2/2) 
    <br/>Mild clinical symptoms 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B89-vaccines-08-00531" ref-type="bibr">89</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Pr4</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p54,p30,p72,p22</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Baculovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Freund’s</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No (0/6) 
    <br/>Delayed clinical disease 
    <br/>Reduced viremia 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B90-vaccines-08-00531" ref-type="bibr">90</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E70</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group1:p158,p327,p14,p220 
    <br/>Group3:p30,p72 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic peptides</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Freund’s</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No; Group1&amp;3 
    <br/>Increased average survival 
    <br/>Reduced mean viral titers 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B95-vaccines-08-00531" ref-type="bibr">95</a>] 
   </td>
  </tr>
  <tr>
   <td colspan="9" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">DNA vaccines</td>
  </tr>
  <tr>
   <td rowspan="2" align="center" valign="middle" colspan="1">E75</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p54/p30 fusion</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">pCMV</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No (0/4)</td>
   <td rowspan="2" align="center" valign="middle" colspan="1">[ 
    <a rid="B92-vaccines-08-00531" ref-type="bibr">92</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">p54/p30/SLA-II fusion</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">pCMV</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">T cell response</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No (0/4) 
    <br/>Viremia enhancement 
   </td>
  </tr>
  <tr>
   <td rowspan="2" align="center" valign="middle" colspan="1">E75</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">sHA/p54/p30 fusion</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">pCMV</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes (p54;p30)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No (0/6);</td>
   <td rowspan="2" align="center" valign="middle" colspan="1">[ 
    <a rid="B93-vaccines-08-00531" ref-type="bibr">93</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">sHA/p54/p30/Ub fusion</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">pCMV</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Strong CTL 
    <br/>IFN-γ 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Partial protection (2/6) 
    <br/>The absence of viremia 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E75</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80 ORFs fragments/Ub fusion</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DNA expression library</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial protection (6/10) 
    <br/>Reduced virus titers 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B94-vaccines-08-00531" ref-type="bibr">94</a>] 
   </td>
  </tr>
  <tr>
   <td colspan="9" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Virus-vectored vaccines</td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">E75</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">sHA 
    <sup>1</sup>/p54/p30fusion 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">BacMam</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Partial protection (4/6) 
    <br/>The absence of viremia 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B97-vaccines-08-00531" ref-type="bibr">97</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Georgia 2007/1</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p30,p54,pp62,p72</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Adenovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">BioMize</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Strong</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γand CTL</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B98-vaccines-08-00531" ref-type="bibr">98</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Georgia 2007/1</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">A151R,B119L,B602L,EP402R∆PRR,B438L,K205R,A104R</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Adenovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">BioMize; 
    <br/>ZTS-01 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Strong</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B96-vaccines-08-00531" ref-type="bibr">96</a>] 
   </td>
  </tr>
  <tr>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Georgia 2007/1</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Ad-ASFV-I: A151R,B119L,B602L,EP402R∆PRR,B438L,K205R,A104R,pp62,p72</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Adenovirus</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">BioMize</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Strong</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No 
    <br/>Immune-response dependent enhancement of disease 
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[ 
    <a rid="B96-vaccines-08-00531" ref-type="bibr">96</a>] 
   </td>
  </tr>
  <tr>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Ad-ASFV-II: p30,p54,pp62,p72,pp220 (p37-34-14,p150-I,p150-II)</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">BioMize</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Higher</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Partial protection: (2/10)</td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ZTS-01</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-γ</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial protection: (5/9) 
    <br/>Lower clinical score 
    <br/>The absence of viremia 
   </td>
  </tr>
  <tr>
   <td colspan="9" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Combined vaccination strategy</td>
  </tr>
  <tr>
   <td rowspan="3" align="center" valign="middle" colspan="1">Georgia 2007/1</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p72, p54, p12</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">HEK 293cell</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">TS6</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Less T Cell response</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td rowspan="3" align="center" valign="middle" colspan="1">[ 
    <a rid="B104-vaccines-08-00531" ref-type="bibr">104</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">p72, C-type Lectin (EP153R), CD2v</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">MVA 
    <sup>2</sup>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">TS6</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">T Cell response</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">p72, C-type Lectin (EP153R), CD2v</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">r VACV 
    <sup>3</sup> prime + protein boost 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">TS6</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">T Cell response 
    <br/>IFN-γ 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Georgia 2007/1</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">47 antigens</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">DNA prime + r VACV boost</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">CpG oligo</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">T Cell response</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No 
    <br/>Reduced viral load 
    <br/>Higher clinical scores 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B105-vaccines-08-00531" ref-type="bibr">105</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">E70;Ba71V</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">DNA:CD2v,p30,p72,CP312R; 
    <br/>Proteins: p15, p35, p54, p72, CD2v-E (s HA) 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">DNA+ Protein</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">ISA25</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">20%; 10%</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Some</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B102-vaccines-08-00531" ref-type="bibr">102</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">Georgia 2007/1; Ba71V</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">DNA:CD2v, p72, p30, +/-p17; 
    <br/>Proteins: p15, p35, p54, +/-p17 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">DNA+ protein</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">ISA25</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Some</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Challenge: Armenia 2007 
    <br/>No 
    <br/>Disease enhancement 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B103-vaccines-08-00531" ref-type="bibr">103</a>] 
   </td>
  </tr>
  <tr>
   <td rowspan="2" align="center" valign="middle" colspan="1">Ba71V</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">p30, p54, p72, s HA/p72</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Alphavirus RPs 
    <sup>4</sup>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td rowspan="2" align="center" valign="middle" colspan="1">[ 
    <a rid="B100-vaccines-08-00531" ref-type="bibr">100</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">p30 (Ba71V) + OURT88/3</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Alphavirus RP prime + LAV boost</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">OUR T88/3</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">A151R, p72, C129R, p30, p54, E146L, I215L, I73R, 
    <br/>L8L, M448R, MGF110-4 L, MGF110-5 L 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">r Ad prime + MVA boost</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Challenge: OUR T88/1 
    <br/>No 
    <br/>Reduced and delayed clinical signs; Reduced viremia and viral load 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B49-vaccines-08-00531" ref-type="bibr">49</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OUR T88/3 
    <br/>Benin 97/1 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p72, p30, p54, E183L, E199L, EP153R, F317L, MGF505-5R</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">r Ad prime + MVA boost</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes (Expect:B646L,E183L,EP153R)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Some (E183L,CP204L)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-γ </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Challenge: OUR T88/1 
    <br/>Exp.2 (6/6) 
    <br/>Reduced Viremia 
    <br/>Infectious virus persisted 
    <br/>Exp.1 (2/6) 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B42-vaccines-08-00531" ref-type="bibr">42</a>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>
    <sup>1</sup> sHA = Extracellular domain of ASFV hemagglutinin; 
    <sup>2</sup> MVA = Modified vaccinia virus Ankara; 
    <sup>3</sup> VACV = Vaccinia virus; 
    <sup>4</sup> RPs = Replicon particles. 
   </p>
  </p>
 </tfoot>
</table>
